HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm battle: procedure vs. pills for double heart trouble
Disease control Recruiting nowThis pilot study is comparing two common treatment approaches for people who have both atrial fibrillation (an irregular heartbeat) and heart failure with preserved heart function. Participants will be randomly assigned to either have a catheter ablation procedure to try to resto…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major trial tests new shot to save lives from common heart failure
Disease control Recruiting nowThis large, late-stage study is testing whether a new injectable drug, maridebart cafraglutide, can help people who have a specific type of heart failure and are also obese. The main goal is to see if the drug, added to standard care, can reduce the risk of dying from heart probl…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC